Medication-induced Dyskinesia

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2024-04-23
Clinical Trial Update: Study to Assess the Safety, Tolerability and Preliminary Efficacy of NLX-112 Versus Placebo in L-dopa-induced Dyskinesia [Phase 2]
Phase 2 trial assessing NLX-112 vs placebo for safety, tolerability, and preliminary efficacy in L-dopa-induced dyskinesia; study completed …